Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined with Atezolizumab and Bevacizumab. Radiol Oncol [Internet]. 2026 Mar. 26 [cited 2026 Oct. 23];60(1):40-8. Available from: https://radioloncol.com/index.php/ro/article/view/4783